CTRI/2012/11/003089已完成4 期
Randomized double-blind placebo controlled clinicaltrial to determine the efficacy of mannitol in reducing intra-compartmental pressure - MRCS study
Christian Medical College Vellore0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients presenting to emergency department with isolated acute, closed and Gustilo Anderson type I open, proximal 2/3rd tibia fracture.
排除标准
- •Patients with contraindication to mannitol are excluded (heart failure, pulmonary congestion, hypotension, anuria, liver failure, intracranial bleed) .
研究者
相似试验
尚未招募
1 期
Randomized double-blind placebo-controlled clinical trial of Jiangtang Xiaozhi decoction for the management of metabolic-associated fatty liver diseasemetabolic-dysfunction-associated fatty liver diseaseITMCTR2024000161Xiyuan Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
Randomized double-blind placebo-controlled clinical observation and central mechanism of acupoint catgut embedding in the treatment of chronic spontaneous urticariaChronic spontaneous urticarialITMCTR2200006839Guang 'anmen Hospital
进行中（未招募）
1 期
The effect of EA-230 on the immuneresponseEUCTR2014-002481-78-NLExponential Biotherapies Inc60
已完成
不适用
Randomized double blind placebo-controlled clinical safety, tolerability and pharmacokinetic/-dynamic study on the effects of escalating single intravenous doses of EA-230 on the innate immune response during experimental human endotoxemiaNL-OMON40791Exponential Biotherapies inc.60
尚未招募
2 期
To Investigate the anti-proliferative and anti-cancer potential of Moclobemide (an anti-depression drug) in castration resistant prostate cancer.CTRI/2023/01/048893ICMR-Product Development Centre at AIIMS New Delhi